Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials

Background. The Meningitis Vaccine Project (MVP) was established to address epidemic meningitis as a public health problem in sub-Saharan Africa and, to that end, worked to develop a group A meningococcal conjugate vaccine, PsA-TT. Methods. Experiences in 4 clinical trial sites are described. Cultur...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Infect Dis
Главные авторы: Idoko, Olubukola T., Diallo, Aldiouma, Sow, Samba O., Hodgson, Abraham, Akinsola, Adebayo, Diarra, Bou, Haidara, Fadima Cheick, Ansah, Patrick Odum, Kampmann, Beate, Bouma, Enricke, Preziosi, Marie-Pierre, Enwere, Godwin C.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2015
Предметы:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639498/
https://ncbi.nlm.nih.gov/pubmed/26553669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ596
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы